Freeman, MD, Joshua. “FDA Approves Alzheimer’s Drug Against the Recommendation of Its Scientific Panel. Be Very Concerned”. RRNMF Neuromuscular Journal, vol. 2, no. 5, Dec. 2021, pp. 5-6, https://doi.org/10.17161/rrnmf.v2i5.15979.